platinum has been researched along with alantolactone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Fang, W; Li, A; Liang, X; Luo, Y; Luo, Z; Lyu, Q; Meng, F; Wang, Y; Zhou, D | 1 |
1 other study(ies) available for platinum and alantolactone
| Article | Year |
|---|---|
Alantolactone-Loaded Pegylated Prodrug Nanocarriers for Synergistic Treatment of Cisplatin-Resistant Ovarian Cancer via Reactivating Mitochondrial Apoptotic Pathway.
Topics: Antineoplastic Agents; Cisplatin; Female; Humans; Lactones; Ovarian Neoplasms; Platinum; Polyethylene Glycols; Prodrugs; Sesquiterpenes, Eudesmane | 2022 |